RBM48

gene
On this page

Also known as DKFZp564O0523HSPC304

Summary

RBM48 (RNA binding motif protein 48, HGNC:21785) is a protein-coding gene on chromosome 7q21.2, encoding RNA-binding protein 48 (Q5RL73). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs. It is a common-essential gene (DepMap: required in 91.7% of cancer cell lines).

Predicted to enable RNA binding activity. Predicted to be involved in RNA splicing and mRNA processing. Located in nucleoplasm.

Source: NCBI Gene 84060 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 87 total — 1 likely-pathogenic
  • Phenotypes (HPO): 1
  • Cancer dependency (DepMap): dependent in 91.7% of screened cell lines (common-essential)
  • MANE Select transcript: NM_032120

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21785
Approved symbolRBM48
NameRNA binding motif protein 48
Location7q21.2
Locus typegene with protein product
StatusApproved
AliasesDKFZp564O0523, HSPC304
Ensembl geneENSG00000127993
Ensembl biotypeprotein_coding
OMIM621015
Entrez84060

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000265732, ENST00000481551, ENST00000496410

RefSeq mRNA: 3 — MANE Select: NM_032120 NM_001363366, NM_001363367, NM_032120

CCDS: CCDS43615

Canonical transcript exons

ENST00000265732 — 5 exons

ExonStartEnd
ENSE000012800819253240492532549
ENSE000012947349253685192540481
ENSE000024623909253440292534970
ENSE000035252789252947692529666
ENSE000038413299252879592528924

Expression profiles

Bgee: expression breadth ubiquitous, 264 present calls, max score 91.40.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.9474 / max 1485.4198, expressed in 1770 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
7952815.94741770

Top tissues by expression

282 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233691.40gold quality
secondary oocyteCL:000065590.88gold quality
oocyteCL:000002387.11gold quality
medial globus pallidusUBERON:000247786.02gold quality
globus pallidusUBERON:000187583.26gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.12gold quality
tendon of biceps brachiiUBERON:000818882.63gold quality
Brodmann (1909) area 9UBERON:001354081.52gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099181.47gold quality
C1 segment of cervical spinal cordUBERON:000646980.49gold quality
corpus callosumUBERON:000233680.27gold quality
right frontal lobeUBERON:000281080.23gold quality
bone marrowUBERON:000237180.11gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450280.02gold quality
dorsolateral prefrontal cortexUBERON:000983479.74gold quality
gastrocnemiusUBERON:000138879.68gold quality
muscle of legUBERON:000138379.45gold quality
spinal cordUBERON:000224079.45gold quality
cerebellar hemisphereUBERON:000224579.44gold quality
cerebellar cortexUBERON:000212979.43gold quality
right hemisphere of cerebellumUBERON:001489079.34gold quality
monocyteCL:000057679.27gold quality
tendonUBERON:000004379.26gold quality
leukocyteCL:000073879.21gold quality
hindlimb stylopod muscleUBERON:000425279.17gold quality
mononuclear cellCL:000084279.00gold quality
granulocyteCL:000009478.90gold quality
lower lobe of lungUBERON:000894978.89gold quality
cerebellumUBERON:000203778.86gold quality
jejunal mucosaUBERON:000039978.42gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.62

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

104 targeting RBM48, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-6851-5P100.0065.631294
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3689D100.0066.141181
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-428299.9975.366408
HSA-MIR-150-5P99.9966.691976
HSA-MIR-366299.9973.825684
HSA-MIR-118499.9968.191458
HSA-MIR-453199.9969.703181
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-433-3P99.9869.371203
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-60799.9773.625593
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-570-3P99.9672.414910
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-218-5P99.9372.222103
HSA-MIR-205-3P99.9269.923165
HSA-MIR-568099.9169.833421
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-129-5P99.8870.263273
HSA-MIR-221-5P99.8665.451052
HSA-MIR-807399.8665.211118

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 91.7% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 1)

  • Genetic analysis of human RNA binding motif protein 48 (RBM48) reveals an essential role in U12-type intron splicing. (PMID:36040194)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriorbm48ENSDARG00000033754
mus_musculusRbm48ENSMUSG00000040302
rattus_norvegicusRbm48ENSRNOG00000008980
drosophila_melanogasterCG34231FBGN0085260

Protein

Protein identifiers

RNA-binding protein 48Q5RL73 (reviewed: Q5RL73)

All UniProt accessions (2): Q5RL73, C9J787

UniProt curated annotations — full annotation on UniProt →

Function. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs.

Subunit / interactions. Component of the minor spliceosome. Within this complex, interacts with ARMC7 and PRPF8/PRP8.

Similarity. Belongs to the RBM48 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q5RL73-11yes
Q5RL73-22

RefSeq proteins (3): NP_001350295, NP_001350296, NP_115496* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR034264RBM48_RRMDomain
IPR035979RBD_domain_sfHomologous_superfamily
IPR039599RBM48Family

UniProt features (20 total): strand 5, helix 3, region of interest 3, sequence conflict 3, turn 2, chain 1, domain 1, compositionally biased region 1, splice variant 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
7DVQELECTRON MICROSCOPY2.89

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5RL73-F168.680.30

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 106 (showing top): DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN, WTGAAAT_UNKNOWN, GOBP_RNA_SPLICING, CDPCR3HD_01, PARENT_MTOR_SIGNALING_UP, TGGAAA_NFAT_Q4_01, GOCC_CATALYTIC_STEP_2_SPLICEOSOME, GOCC_SPLICEOSOMAL_COMPLEX, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, GOBP_MRNA_PROCESSING, SHEN_SMARCA2_TARGETS_UP, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES

GO Biological Process (2): mRNA processing (GO:0006397), RNA splicing (GO:0008380)

GO Molecular Function (3): RNA binding (GO:0003723), nucleic acid binding (GO:0003676), protein binding (GO:0005515)

GO Cellular Component (2): nucleoplasm (GO:0005654), spliceosomal complex (GO:0005681)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA processing2
binding2
mRNA metabolic process1
nucleic acid binding1
nuclear lumen1
cellular anatomical structure1
nuclear protein-containing complex1
ribonucleoprotein complex1

Protein interactions and networks

STRING

1612 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RBM48ARMC7Q9H6L4766
RBM48FAM133BQ5BKY9540
RBM48FAM186BQ8IYM0525
RBM48THAP8Q8NA92507
RBM48GATAD1Q8WUU5506
RBM48ANKIB1Q9P2G1477
RBM48HEPACAM2A8MVW5438
RBM48ZNF483Q8TF39398
RBM48SCNM1Q9BWG6394
RBM48FAM168BA1KXE4371
RBM48TMEM243Q9BU79370
RBM48ZNF713Q8N859364
RBM48VMA22Q96NT0358
RBM48THOC3Q96J01354
RBM48ALKBH6Q3KRA9347

IntAct

124 interactions, top by confidence:

ABTypeScore
RBM48ARMC7psi-mi:“MI:0915”(physical association)0.800
TEKT4RBM48psi-mi:“MI:0915”(physical association)0.560
S100ZRBM48psi-mi:“MI:0915”(physical association)0.560
PIBF1RBM48psi-mi:“MI:0915”(physical association)0.560
RBM48EIF1ADpsi-mi:“MI:0915”(physical association)0.560
RBM48TSR2psi-mi:“MI:0915”(physical association)0.560
RBM48KIF9psi-mi:“MI:0915”(physical association)0.560
CCDC57RBM48psi-mi:“MI:0915”(physical association)0.560
RBM48ATPAF2psi-mi:“MI:0915”(physical association)0.560
MLH1RBM48psi-mi:“MI:0915”(physical association)0.560
RAD51DRBM48psi-mi:“MI:0915”(physical association)0.560
RBM48NTAQ1psi-mi:“MI:0915”(physical association)0.560
RBM48TBC1D22Bpsi-mi:“MI:0915”(physical association)0.560
RBM48SPRED2psi-mi:“MI:0915”(physical association)0.560
COX5BRBM48psi-mi:“MI:0915”(physical association)0.560
POLR1CRBM48psi-mi:“MI:0915”(physical association)0.560
AMOTRBM48psi-mi:“MI:0915”(physical association)0.560
PRKAB2RBM48psi-mi:“MI:0915”(physical association)0.560
RBM48FAM90A1psi-mi:“MI:0915”(physical association)0.560
GYS1RBM48psi-mi:“MI:0915”(physical association)0.560
RBM48JMYpsi-mi:“MI:0915”(physical association)0.560
HSF2BPRBM48psi-mi:“MI:0915”(physical association)0.560
RBM48TEKT4psi-mi:“MI:0915”(physical association)0.560
RBM48SCNM1psi-mi:“MI:0915”(physical association)0.560
RBM48S100Zpsi-mi:“MI:0915”(physical association)0.560
NUDT21RBM48psi-mi:“MI:0915”(physical association)0.550
TK1RBM48psi-mi:“MI:0915”(physical association)0.550
RBM48NBEApsi-mi:“MI:0914”(association)0.530

BioGRID (93): RBM48 (Affinity Capture-MS), ARMC7 (Affinity Capture-MS), ARMC7 (Affinity Capture-Western), RBM48 (Affinity Capture-Western), NBEA (Affinity Capture-MS), ARMC7 (Affinity Capture-MS), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid)

ESM2 similar proteins: A4FVJ7, A6QPE1, E7F7X0, F1Q8J0, O43683, O60566, P92204, Q08AZ1, Q0VBD2, Q32NQ8, Q3MHP0, Q3UZ01, Q4G055, Q4R707, Q561R3, Q5F3D1, Q5HZN1, Q5R4U2, Q5R6C7, Q5R789, Q5RL73, Q5SPR8, Q5ZIX8, Q6DD45, Q6DE94, Q6DJS0, Q6GQJ2, Q6IE81, Q6IRB8, Q6NZY4, Q6P2L6, Q6XV80, Q6ZPI0, Q76FK4, Q7L590, Q7ZVP1, Q7ZXG4, Q801E2, Q8JZV4, Q8K298

Diamond homologs: A4FVJ7, A6QPE1, Q561R3, Q5R4U2, Q5RL73, Q8K2X2

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 75 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Transcriptional Regulation by TP5379.1×4e-03

GO biological processes:

GO termPartnersFoldFDR
regulation of G1/S transition of mitotic cell cycle522.5×1e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

87 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance56
Likely benign10
Benign13

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
548642NM_032120.4(RBM48):c.835A>G (p.Thr279Ala)Likely pathogenic

SpliceAI

594 predictions. Top by Δscore:

VariantEffectΔscore
7:92529626:G:GTdonor_gain1.0000
7:92532398:A:AGacceptor_gain1.0000
7:92532399:T:Gacceptor_gain1.0000
7:92532400:TCA:Tacceptor_loss1.0000
7:92532401:CA:Cacceptor_loss1.0000
7:92532402:A:ACacceptor_loss1.0000
7:92532402:A:AGacceptor_gain1.0000
7:92532402:AG:Aacceptor_gain1.0000
7:92532403:G:GTacceptor_gain1.0000
7:92532403:GG:Gacceptor_gain1.0000
7:92532403:GGAC:Gacceptor_gain1.0000
7:92532403:GGACA:Gacceptor_gain1.0000
7:92532515:G:GTdonor_gain1.0000
7:92532519:GCA:Gdonor_gain1.0000
7:92532526:T:TAdonor_gain1.0000
7:92532527:A:AAdonor_gain1.0000
7:92536549:G:GGdonor_gain1.0000
7:92536847:TTA:Tacceptor_loss1.0000
7:92536848:TAG:Tacceptor_loss1.0000
7:92536850:G:GAacceptor_loss1.0000
7:92536850:GGTA:Gacceptor_gain1.0000
7:92529470:TTTCA:Tacceptor_loss0.9900
7:92529471:TTCAG:Tacceptor_loss0.9900
7:92529473:CA:Cacceptor_loss0.9900
7:92529474:A:ATacceptor_loss0.9900
7:92529475:GGTAT:Gacceptor_gain0.9900
7:92529663:CAAGG:Cdonor_loss0.9900
7:92529666:GGT:Gdonor_loss0.9900
7:92529667:G:Cdonor_loss0.9900
7:92529668:T:Gdonor_loss0.9900

AlphaMissense

2408 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:92532413:G:CK104N0.998
7:92532413:G:TK104N0.998
7:92529636:T:CL91P0.997
7:92529498:C:TS45F0.996
7:92529620:T:CF86L0.996
7:92529622:T:AF86L0.996
7:92529622:T:GF86L0.996
7:92532409:C:AA103D0.996
7:92529497:T:CS45P0.995
7:92529513:T:AI50K0.995
7:92529645:T:CF94S0.995
7:92532466:C:AA122D0.995
7:92529632:T:GY90D0.994
7:92529507:T:CL48S0.993
7:92529522:T:AV53D0.993
7:92529644:T:CF94L0.993
7:92529646:T:AF94L0.993
7:92529646:T:GF94L0.993
7:92532457:T:AV119E0.993
7:92529503:T:GY47D0.992
7:92529513:T:GI50R0.992
7:92532451:T:AL117H0.992
7:92528892:T:CY27H0.991
7:92529639:T:AI92N0.991
7:92532404:G:CR101S0.991
7:92532404:G:TR101S0.991
7:92532435:T:CF112L0.991
7:92532437:C:AF112L0.991
7:92532437:C:GF112L0.991
7:92532453:C:GH118D0.991

dbSNP variants (sampled 300 via entrez): RS1000014747 (7:92537605 A>G), RS1000317139 (7:92539844 C>G), RS1000490837 (7:92537842 T>A), RS1000791010 (7:92529341 T>G), RS1000885834 (7:92529557 C>A,G), RS1000961060 (7:92533786 A>G), RS1001016310 (7:92533989 AC>A), RS1001035485 (7:92540156 A>G), RS1001092109 (7:92539128 A>T), RS1001231526 (7:92534341 G>A), RS1001240192 (7:92527023 G>C,T), RS1001461533 (7:92538823 C>G), RS1003017067 (7:92530933 C>G,T), RS1003074677 (7:92539712 C>T), RS1003129252 (7:92537747 C>G,T)

Disease associations

OMIM: gene MIM:621015 | disease phenotypes: MIM:256100

GenCC curated gene-disease

Mondo (1): nephronophthisis (MONDO:0019005)

Orphanet (1): Nephronophthisis (Orphanet:655)

HPO phenotypes

1 total (1 of 1 shown, HPO-id order):

HPOTerm
HP:0000090Nephronophthisis

GWAS associations

3 associations (top):

StudyTraitp-value
GCST005588_34Idiopathic dilated cardiomyopathy7.000000e-06
GCST012227_124Hip circumference adjusted for BMI1.000000e-10
GCST90020028_173Hip circumference adjusted for BMI2.000000e-10

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0009094idiopathic dilated cardiomyopathy
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

30 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases abundance, increases expression3
Air Pollutantsaffects expression, increases abundance, decreases expression2
Formaldehydedecreases expression, increases expression2
Tobacco Smoke Pollutionincreases expression2
Valproic Acidaffects expression, decreases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
methylmercuric chloridedecreases expression1
propionaldehydedecreases expression1
lei gong tengincreases expression1
epigallocatechin gallateincreases expression1
di-n-butylphosphoric acidaffects expression1
cylindrospermopsinincreases expression1
abrineincreases expression1
jinfukangaffects cotreatment, decreases expression1
MT19c compoundincreases expression1
Leflunomideincreases expression1
Arsenicincreases abundance, increases expression1
Cisplatindecreases expression, affects cotreatment1
Coalincreases abundance, decreases expression1
Copperaffects binding, decreases expression1
Disulfiramdecreases expression, affects binding1
Folic Aciddecreases expression1
Hydrogen Peroxidedecreases expression1
Methyl Methanesulfonateincreases expression1
Ozoneaffects expression, increases abundance1
Phenylmercuric Acetatedecreases expression1
Smokedecreases expression, increases abundance1
Urethaneaffects expression1
Acrylamideincreases expression1
Particulate Matterincreases expression1

Clinical trials (associated diseases)

6 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT01022957Not specifiedCOMPLETEDNephronophthisis : Clinical and Genetic Study
NCT01401998Not specifiedRECRUITINGARPKD Database Study
NCT04874909Not specifiedCOMPLETEDClassification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
NCT05286632Not specifiedCOMPLETEDKidneYou - Innovative Digital Therapy
NCT06065852Not specifiedRECRUITINGNational Registry of Rare Kidney Diseases
NCT06648044Not specifiedRECRUITINGResearch of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies
  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): nephronophthisis